摘要
目的:分析在体外循环心脏瓣膜置换术患者中实施右美托咪定联合舒芬太尼的作用。方法:选择在本院实施体外循环心脏瓣膜置换术治疗84例患者(2021年3月至2023年3月),根据随机数表法分为两组(对照组共计42例,实施舒芬太尼麻醉;观察组共计42例,实施舒芬太尼+右美托咪定麻醉)。比较两组麻醉效果、器官保护作用及不良反应发生率。结果:两组组间的麻醉效果、器官保护作用对比,观察组均相比对照组较好(P<0.05);观察组不良反应发生率7.14%相比对照组的21.43%较低(P<0.05)。结论:体外循环心脏瓣膜置换术患者采用联合右美托咪定与舒芬太尼进行麻醉,效果良好,不仅能对机体器官组织加以保护,还能在一定程度上积极防控不良反应的发生。
Objective:To analyze the effect of dexmedetomidine combined with sufentanil in patients undergoing cardiopulmo-nary bypass heart valve replacement.Methods:A total of 84 patients(March 2021~March 2023)were selected to receive car-diopulmonary bypass heart valve replacement in our hospital,and were divided into two groups according to random number ta-ble method(Sufentanil anesthesia was administered to 42 patients in the control group.A total of 42 patients in the observation group received Sufentanil+dexmedetomidine anesthesia).The anesthesia effect,organ protection and the incidence of adverse reactions were compared between the two groups.Results:The anesthesia effect and organ protection effect between the two groups were better in the observation group than in the control group(P<0.05).The incidence of adverse reactions in the ob-servation group(7.14%)was lower than that in the control group(21.43%)(P<0.05).Conclusion:The combination of dexmedetomidine and sufentanil for anesthesia in patients with cardiopulmonary bypass heart valve replacement has a good effect,which can not only protect the body organs and tissues,but also actively prevent and control the occurrence of adverse reactions to a certain extent.
作者
李凤利
陈伟
Li Fengi;Chen Wei(Linyi Central Hospital,Linyi Shandong,276400,China)
出处
《中外女性健康研究》
2024年第2期45-47,共3页
Women＇s Health Research
关键词
体外循环心脏瓣膜置换术
右美托咪定
舒芬太尼
Extracorporeal circulation heart valve replacement surgery
Dexmetomidine
Sufentanil
